Eric M. Horwitz, MD
Fox Chase Cancer Center
333 Cottman Ave
Philadelphia, PA 19111-2497
Top Doctors 2015
- John Donahue - Radiation Treatment for Prostate Cancer Patient Stories
- Thomas Donnelly - Anorectal Cancer Patient Stories
- Ed Horowitz - Radiation Treatment for Prostate Cancer Patient Stories
- James Ferraro - Esophageal Cancer Patient Stories
- Michael Kostic - Head and Neck Cancer Patient Stories, Plastic and Reconstructive Surgery Patient Stories, Radiation Treatment for Prostate Cancer Patient Stories
- Kevin Logan - Head and Neck Cancer Patient Stories, Squamous Cell Cancer Patient Stories
- James Slade - Prostate Cancer Patient Stories, Colon Cancer Patient Stories, Radiation Treatment for Prostate Cancer Patient Stories
- R. Hallock Williams, MD - Skin Cancer Patient Stories, Radiation Treatment for Prostate Cancer Patient Stories
(Feb 11, 2013)
Rethinking the value & risks of cancer screening
Dr. Horwitz on WHYY's Radio Times, discussing screening guidelines. November 3, 2011.
Listen at WHYY FM
Confronting Cancer Today
See Dr. Eric Horwitz discuss cancer treatment on NBC's Today Show, June 12, 2009.
Watch at NBC.com
Chairman, Radiation Oncology
Gerald E. Hanks Chair in Radiation Oncology
Meet other members of the
genitourinary cancer treatment team.
Prostate Cancer; ; (IMRT); (IGRT); Stereotactic Radiotherapy (SRT)
American Board of Radiology, Radiation Oncology
I joined Fox Chase's department of radiation oncology in 1997. In my practice, I specialize in treating patients with prostate cancer.
At Fox Chase, I have had the opportunity to develop advanced programs that include intensity modulated radiation therapy (IMRT), real-time intra-operative treatment planning for permanent prostate seed implants and temporary high-dose-rate (HDR) brachytherapy for prostate cancer. As a result, Fox Chase was the first in the Northeast United States to offer HDR implants to men with prostate cancer. As a radiation oncologist at Fox Chase, I have been privileged to be able to use these technologies to improve and expand the treatment of men with prostate cancer. Over the past decade, we have developed one of the largest, most sophisticated, brachytherapy programs in the region.
In addition, I have been involved in the development and first use of many image guidance techniques to improve the radiation treatment for men with prostate cancer including the BAT ultrasound, Calypso beacons and MRI treatment simulator for prostate cancer treatment planning. We have successfully integrated the routine use MRI into treatment planning for patients treated with IMRT, permanent, seed prostate implants, and temporary high dose rate prostate implants. Fox Chase was the first North America to use the MRI simulator in radiation treatment planning.
Fox Chase was also one of the first hospitals to use Calypso® - brand new 4-dimensional monitoring technology, which allows us to more precisely and accurately guide radiation therapy. Miniature electromagnetic sensors (similar to seeds), called Beacon® transponders, are implanted into the prostate during treatment planning to continuously monitor position and motion of the organ in real-time. This technology helps us determine a tumor's location with great accuracy and continuously monitor its position throughout treatment.
In addition to my focus on treating and caring for men with prostate cancer, it is my responsibility as Chairman of the Department of Radiation Oncology at Fox Chase; an NCI designated National Comprehensive Cancer Center to promote the mission of the Center to prevail over cancer, marshaling heart and mind in bold scientific discovery, pioneering prevention, and compassionate care. Our department's expertise has always focused on developing and integrating sophisticated technology into successful treatment for our cancer patients and I remain committed to continuing and expanding this legacy. However, the successful treatment of a patient is not just based on the technology that is available. Being diagnosed with cancer and receiving treatment is one of the most difficult things that many people will ever face, and it is crucial that we as caregivers do not forget this. Caring for patients as one important part of a multidisciplinary team allows us in the Department of Radiation Oncology to provide the best possible care for our patients.
Albany Medical College, Albany, N.Y., 1992
Radiation Oncology, William Beaumont Hospital, Royal Oak, Mich.
Honors and Awards
Philadelphia Magazine Top Doctors 2002-2015
Best Doctors in America® 2013-2014
Determining outcomes in treatment for prostate cancer patients treated with external beam radiation and brachytherapy;
Developing image guidance techniques for prostate cancer radiation;
Developing new bladder preservation techniques to treat patients with muscle invasive bladder cancer
Hanks, G.E.; Hanlon, A.L.; Epstein, B.; Horwitz, E.M. Dose response in prostate cancer with 8-12 year follow-up. International Journal of Radiation Oncology Biology and Physics 54: 427-435; 2002. PMID: 12243818
Horwitz, E.M.; Uzzo, R.G.; Hanlon, A.L.; Greenberg, R.E.; Hanks, G.E.; Pollack, A. Modifying the ASTRO definition of biochemical failure to minimize the influence of backdating in patients with prostate cancer treated with 3D conformal radiation therapy alone. Journal of Urology 169: 2153-2159; 2003. PMID: 12771738
Horwitz, E.M.; Thames, H.D.; Kuban, D.A.; Levy, L.B.; Kupelian, P.A.; Martinez, A.A.; Michalski, J.M.; Pisansky T.M.; Sandler, H.M.; Shipley, W.U.; Zelefsky, M.J.; Hanks, G.E.; Zietman, A.L. Definitions Of Biochemical Failure That Best Predict Clinical Failure In Prostate Cancer Patients Treated With External Beam Radiation Alone - A Multi-Institutional Pooled Analysis. Journal of Urology 173:797-802; 2005. PMID: 15711272
Kuban, D.A.; Levy, L.B.; Potters, L.; Beyer, D.C.; Blasko, J.C.; Moran, B.J.; Ciezki, J.P.; Zietman, A.L.; Zelefsky, M.J.; Pisansky, T.M.; Elshaikh, M.; Horwitz, E.M. Comparison of biochemical failure definitions for permanent prostate brachytherapy. International Journal of Radiation Oncology Biology and Physics 65: 1487-1493; 2006. PMID: 16750326
Horwitz, E.M.; Levy, L.B.; Thames, H.D.; Kuban, D.A.; Kupelian, P.A.; Martinez, A.A.; Michalski, J.M.; Pisansky T.M.; Sandler, H.M.; Shipley, W.U.; Zelefsky, M.J.; Hanks, G.E.; Zietman, A.L. The Biochemical And Clinical Significance Of The Post-Treatment PSA Bounce For Prostate Cancer Patients Treated With External Beam Radiation Therapy Alone: A Multi-Institutional Pooled Analysis. Cancer 1071: 1496-1502; 2006. PMID: 16944536
Langer, C.J.; Harris, J.; Horwitz, E.M.; Nicolaou, N.; Kies, M.; Curran, W.J.; Wong, S.J.; Ang, K.K. Phase II study of paclitaxel, cisplatin in combination with split course concomitant hyperfractionated re-irradiation in patients with recurrent squamous cell cancer of the head and neck cancer: Preliminary results of RTOG 99-11. Journal of Clinical Oncology 25: 4800-4805; 2007. PMID: 17947728
My NCBI Collection